← FDA DRUG APPROVALS

FDA ANDA · ANDA083799

IMIPRAMINE HYDROCHLORIDE

Sponsor: ROXANE

APPLICATION
ANDA083799
TYPE
ANDA
ORIGINAL APPROVAL
1977-08-05
LATEST ACTION
1994-02-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IMIPRAMINE HYDROCHLORIDEDiscontinued
IMIPRAMINE HYDROCHLORIDE 25MG · TABLET · ORAL
IMIPRAMINE HYDROCHLORIDEDiscontinued
IMIPRAMINE HYDROCHLORIDE 50MG · TABLET · ORAL
IMIPRAMINE HYDROCHLORIDEDiscontinued
IMIPRAMINE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

1994-02-09Labeling · Supplement 21AP
1990-10-19Labeling · Supplement 20AP
1989-09-15Labeling · Supplement 19AP
1977-08-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →